Hohensee et al. displayed that EGFR mutations were relatively more common in brain metastasis than other distant metastases or primary tumors, suggesting that TNBC patients with EGFR variation are at high risk of developing brain metastases.28 The gene discussed is EGFR; the disease is metastasis.